Dormant tumor cells develop cross-resistance to apoptosis induced by CTLs or imatinib mesylate via methylation of suppressor of cytokine signaling 1.

Source:http://linkedlifedata.com/resource/pubmed/id/17483365

Cancer Res. 2007 May 1 67 9 4491-8

Download in:

View as

General Info

PMID
17483365